Strategic consultancy for pharmaceutical registration, lifecycle management, and authority-facing interactions across global markets.
Lumicure Pharma provides world-class Regulatory Affairs consulting services designed to navigate the complex landscape of global pharmaceutical regulations. Our expert team acts as your strategic partner, guiding you through every step of the product lifecycle—from initial development strategy to marketing authorization and post-approval maintenance.
We specialize in submissions for the Egyptian Drug Authority (EDA), Saudi Food & Drug Authority (SFDA), and other MENA region authorities, as well as international bodies like the FDA and EMA. Our deep understanding of local and international guidelines ensures that your submissions are accurate, compliant, and optimized for fast approval.
Development of tailored regulatory roadmaps for product development and market launch timelines.
Expert preparation and management of complex submissions including MAA, NDA, and CTD dossiers.
Support for variations, renewals, line extensions, and comprehensive post-marketing management.
Strategic support for scientific advice meetings and efficient responses to authority queries.
Our expertise spans multiple global jurisdictions, ensuring your products meet the highest compliance standards:
Deep knowledge of drugs, biologics, and medical devices registration pathways (Centralized, DCP, MRP).
Specialized expertise for the Saudi and Gulf markets, including platform-ready submissions.
End-to-end support for product registration and lifecycle management in the Egyptian market.
Our team is ready to discuss your regulatory challenges today.
Contact Experts
